Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio : vimarsana.com

- Expected to be Immediately and Highly Accretive Driven by Identified Annual Synergies of at Least $75 Million -

Related Keywords

Massachusetts , United States , Alex Dasalla , Jeff Bailey , Joe Ciaffoni , Hamilton Sanders , Purdue Pharma , Us Drug Enforcement Agency , Nasdaq , Collegium Pharmaceutical Inc , Corporate Communications , Moelis Company , Biodelivery Sciences International Inc , Goodwin Procter , Highly Accretive Driven , Identified Annual Synergies , Diversify Revenue Growth , Accelerate Cash Flow Generation , Second Growth Driver , Establishes Foothold , Call Scheduled , Biodelivery Sciences International , Chief Executive Officer , Pharmakon Advisors , Troutman Pepper , Pharmaceutical Investor Call , Collegium Pharmaceutical , Delivery Sciences International , Private Securities Litigation Reform Act , Enforcement Agency , Quarterly Reports , Recommendation Statement , Investor Relations , ,